Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Gynaecol Obstet. 2008 Nov;103(2):149-52. doi: 10.1016/j.ijgo.2008.06.012. Epub 2008 Aug 29.

Isolation of human mesenchymal stem cells from third-trimester amniotic fluid.

Author information

  • 1Stem Cell Investigation Center, Department of Gynecology and Obstetrics, Harbin Medical University, Heilongjiang, China.

Abstract

OBJECTIVE:

To determine whether mesenchymal stem cells (MSCs) can be isolated in third-trimester amniotic fluid (AF) and their differentiation induced.

METHOD:

Sufficient numbers of MSCs were isolated from the AF of 15 healthy women undergoing cesarean delivery in the third trimester to be cultured and induced to differentiate into osteocytes.

RESULTS:

Reverse-transcriptase polymerase chain reaction showed the MSCs to express the pluripotency marker gene OCT4, and flow cytometry showed these cells to be positive for CD29, CD73, CD90, and CD105 and negative for CD31, CD45, and CD61. The MSCs were also determined to be nontumorigenic.

CONCLUSION:

Multipotent MSCs can be obtained from AF in the third trimester, which may be less dangerous than the second trimester to women and their fetuses.

PMID:
18760782
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk